Showing results (111-120 of 123) with videos related to
Sort By:
Pageof 13
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 30, 1999
Tat toxoid as a component of a preventive vaccine in seronegative subjectsA Gringeri, E Santagostino, M Muça-Perja, et al.Journal of Neurovirology|November 13, 2001
CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infectionT Fischer-Smith, S Croul, A E Sverstiuk, et al.Science (New York, N.Y.)|June 30, 2012
The tides of TitanLuciano Iess, Robert A Jacobson, Marco Ducci, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 3, 1999
New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDSH Hendel, S Caillat-Zucman, H Lebuanec, et al.Immunogenetics|March 26, 2004
Genomic analysis of Fas and FasL genes and absence of correlation with disease progression in AIDSA Vasilescu, S C Heath, G Diop, et al.Proceedings of the National Academy of Sciences of the United States of America|May 9, 1998
Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDSD Zagury, A Lachgar, V Chams, et al.Genes and Immunity|August 29, 2003
Genomic analysis of Th1-Th2 cytokine genes in an AIDS cohort: identification of IL4 and IL10 haplotypes associated with the disease progressionA Vasilescu, S C Heath, R Ivanova, et al.Journal of Human Virology|April 9, 1999
Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patientsA Gringeri, E Santagostino, M Muça-Perja, et al.Proceedings of the National Academy of Sciences of the United States of America|May 9, 1998
C-C chemokines, pivotal in protection against HIV type 1 infectionD Zagury, A Lachgar, V Chams, et al.Journal of Human Virology|April 9, 1999
Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccineJ F Zagury, A Sill, W Blattner, et al.Pageof 13